TLR7 and systemic lupus erythematosus: Pristane treatment results in the formation of lipogranulomas and the overexpression of IFN-inducible genes [22], which closely resembles the IFN-I-induced gene expression signature seen in blood cells derived from human patients with SLE [23,24] and is dependent on TLR7 [25].